title: Sulfasalazine-induced fulminant hepatitis in pediatric Crohn's disease: report of two cases.
authors.affiliation: Service de Gastro-entérologie Pédiarique, Hôpital Robert Debré, Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Besnard
authors.forename: D
authors.initials: D
authors.lastname: Debray
authors.forename: P
authors.initials: P
authors.lastname: Durand
authors.forename: J P
authors.initials: JP
authors.lastname: Cézard
authors.forename: J
authors.initials: J
authors.lastname: Navarro
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000601:surgery; D002648:Child; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D012460:Sulfasalazine